ELIZABETH WALSH: Open Payments
NPI 1215998216 · MANCHESTER, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 17 payments from 6 companies in 2025. Trend: 2023 $221 · 2024 $17 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $156 |
| Boston Scientific Corporation | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Amgen Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
Products named: DUPIXENT, WATCHMAN FLX, COSENTYX, OTEZLA, EBGLYSS, Zoryve.
Industry payments across CT — which companies pay providers there.
